0000899243-21-034083.txt : 20210824 0000899243-21-034083.hdr.sgml : 20210824 20210824204420 ACCESSION NUMBER: 0000899243-21-034083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210820 FILED AS OF DATE: 20210824 DATE AS OF CHANGE: 20210824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kushner Joshua CENTRAL INDEX KEY: 0001844181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40154 FILM NUMBER: 211203410 MAIL ADDRESS: STREET 1: C/O OSCAR HEALTH, INC. STREET 2: 75 VARICK STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oscar Health, Inc. CENTRAL INDEX KEY: 0001568651 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 403-3677 MAIL ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: Mulberry Health Inc. DATE OF NAME CHANGE: 20130204 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-20 0 0001568651 Oscar Health, Inc. OSCR 0001844181 Kushner Joshua 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 1 1 1 0 Co-Founder and Vice Chairman Class A Common Stock 2021-08-20 4 P 0 68542 13.4107 A 68542 I See footnote Class A Common Stock 2021-08-23 4 P 0 125900 13.0104 A 194442 I See footnote Class A Common Stock 2021-08-24 4 P 0 1074342 12.69 A 1268784 I See footnote Represents: (i) 67,726 shares of Class A common stock purchased by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and (ii) 816 shares of Class A common stock purchased by Claremount VII Associates, L.P. ("Claremount VII"). The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.12 to $13.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations of Rule 10b-18. Shares held directly by Thrive VII Growth and Claremount VII. Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII and Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of each of Thrive Partners VII Growth and Thrive Partners VII, and, in his capacity as managing member, has voting and investment power over the shares held by each of Thrive VII Growth and Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth and Claremount VII except to the extent of their pecuniary interest therein. Represents: (i) 124,401 shares of Class A common stock purchased by Thrive VII Growth and (ii) 1,499 shares of Class A common stock purchased by Claremount VII. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.83 to $13.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations of Rule 10b-18. Represents: (i) 1,061,552 shares of Class A common stock purchased by Thrive VII Growth and (ii) 12,790 shares of Class A common stock purchased by Claremount VII. All shares were purchased in accordance with the daily volume and other limitations of Rule 10b-18. /s/ Joshua Kushner 2021-08-24